iShares Biotechnology ETF (NASDAQ:IBB) Shares Sold by First Interstate Bank

First Interstate Bank decreased its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 2.4% during the fourth quarter, HoldingsChannel reports. The firm owned 42,428 shares of the financial services provider’s stock after selling 1,059 shares during the quarter. First Interstate Bank’s holdings in iShares Biotechnology ETF were worth $5,764,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in IBB. Moneta Group Investment Advisors LLC increased its stake in shares of iShares Biotechnology ETF by 131,598.4% in the fourth quarter. Moneta Group Investment Advisors LLC now owns 4,469,845 shares of the financial services provider’s stock worth $586,846,000 after acquiring an additional 4,466,451 shares during the period. JPMorgan Chase & Co. lifted its stake in shares of iShares Biotechnology ETF by 159.9% in the first quarter. JPMorgan Chase & Co. now owns 1,966,359 shares of the financial services provider’s stock worth $253,975,000 after buying an additional 1,209,700 shares in the last quarter. International Assets Investment Management LLC purchased a new position in shares of iShares Biotechnology ETF in the fourth quarter worth about $76,425,000. Goldman Sachs Group Inc. lifted its stake in shares of iShares Biotechnology ETF by 49.9% in the first quarter. Goldman Sachs Group Inc. now owns 1,568,159 shares of the financial services provider’s stock worth $204,332,000 after buying an additional 521,820 shares in the last quarter. Finally, Itau Unibanco Holding S.A. purchased a new position in shares of iShares Biotechnology ETF in the third quarter worth about $48,242,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

Shares of NASDAQ:IBB traded down $0.87 during midday trading on Tuesday, hitting $126.97. The company’s stock had a trading volume of 1,753,613 shares, compared to its average volume of 1,808,489. iShares Biotechnology ETF has a 12-month low of $111.83 and a 12-month high of $141.16. The business’s 50 day simple moving average is $135.63 and its 200 day simple moving average is $129.57.

iShares Biotechnology ETF Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, March 27th. Investors of record on Friday, March 22nd were given a dividend of $0.126 per share. This represents a $0.50 annualized dividend and a yield of 0.40%. The ex-dividend date was Thursday, March 21st.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.